Abstract
Eosinophilic esophagitis (EoE) is an emerging chronic T helper type 2 (Th2)-associated, allergic, and immune-mediated disease, characterized histologically by eosinophil-predominant mucosal inflammation and clinically by esophageal dysfunction. Over the past years, the prevalence of EoE has dramatically increased globally. Until recently, most studies of EoE focused on using human biopsies, which are also used for diagnostic purposes, or esophageal epithelial cell lines, which led to major advances in the understanding of EoE. Despite this, a robust mouse model that mimics human disease is still crucial for both understanding disease pathogenesis and as a preclinical model for testing future therapeutics. Herein, we describe a highly reproducible and robust model of EoE that can be performed using wild-type mice by ear sensitization with oxazolone (OXA) followed by intraesophageal challenges. Experimental EoE elicited by OXA mimics the main histopathological features of human EoE, including intraepithelial eosinophilia, epithelial and lamina propria thickening, basal cell hyperplasia, and fibrosis.
Original language | English |
---|---|
Article number | e993 |
Journal | Current Protocols |
Volume | 4 |
Issue number | 2 |
DOIs | |
State | Published - Feb 2024 |
Keywords
- IL-13
- IL-4
- atopic dermatitis (AD)
- eosinophilic esophagitis (EoE)
- eosinophils
- esophagus
- oxazolone (OXA)
All Science Journal Classification (ASJC) codes
- General Immunology and Microbiology
- General Pharmacology, Toxicology and Pharmaceutics
- Medical Laboratory Technology
- General Biochemistry,Genetics and Molecular Biology
- Health Informatics
- General Neuroscience